About FormBlends Reviews

What this site is, who writes it, the conflict of interest in plain words, how evaluations are produced and corrected, what the site refuses to publish, and how to reach the editorial team.

Last updated September 4, 2026

FormBlends Reviews is the evaluation desk of the FormBlends network. It reads the public pages of GLP-1 telehealth programs and manufacturer direct-to-patient pharmacies, scores what they publish against eight written criteria, and shows the page and the date behind every score. It publishes no user reviews, no star ratings and no rankings.

Who runs it

The FormBlends editorial team, which also publishes formblends.com and the other sites in the network. FormBlends operates a GLP-1 weight-loss program that dispenses compounded semaglutide and tirzepatide through licensed 503A pharmacies. That program competes directly with several of the programs evaluated here.

We do not think that disqualifies the site. We think it obliges it to do three things, which it does: state the conflict on every evaluation page and in the comparison tool; publish the rubric before the scores so a score has to fit a written definition; and score FormBlends on the same rubric, in public, with its weak rows visible. The conflict of interest page has the full statement and the FormBlends evaluation is the result.

What the site contains

  • Methodology. The rubric (eight criteria, four written levels each), how we evaluate (the fixed reading list and process), and the conflict statement.
  • Evaluations. Twelve programs: Ro, Hims and Hers, Noom Med, WeightWatchers Clinic, Found, Calibrate, Henry Meds, Mochi Health, Ivim Health, LillyDirect, NovoCare Pharmacy, and FormBlends. Each page reproduces what the company publishes about its offer, medications, prices, prescriber model, pharmacy sourcing and refund terms, with the URL and access date; reports any primary regulatory document in a separate section; scores the eight criteria with a one-line reason each; and ends with what to ask them.
  • Guides. The red flags checklist, questions to ask before paying, reading a certificate of analysis as a buyer, how refund windows work, how to check a prescriber's licence, and how to sort brand from compounded on a program page.
  • Tool. The provider comparison builder: pick up to three evaluated programs and see the rubric rows side by side, with the disclosure on every view and in every copy.

Editorial process, in short

Same pages, same order, same definitions, second reader on every score, lower score when two definitions fit, unknown printed as unknown. The full procedure is on the how we evaluate page. No mystery shopping, no accounts created, no private correspondence used. Prices and refund pages are re-read at least quarterly; every change to a published score is dated in the page's change log.

What we refuse to publish

  • User reviews, testimonials, star ratings, or scores aggregated from other sites. We cannot verify them, and a market participant publishing ratings of its competitors is the situation the FTC's endorsement and consumer-review rules exist for.
  • Named clinicians, "medically reviewed by" lines, or any claim of clinical review that did not happen. The byline on every page is the FormBlends editorial team.
  • Regulatory allegations without a primary document. If we cannot link the warning letter, order, filing or press release, it is not on the page.
  • Language that calls a compounded GLP-1 approved, generic, or equivalent to Wegovy, Ozempic, Zepbound or Mounjaro. Compounded drugs are not FDA approved and are not interchangeable with the brand products. That applies to FormBlends' products as much as anyone's.
  • Paid placements, affiliate links, sponsorships or advertising, from any evaluated company including FormBlends' own program.

Corrections and re-checks

If a score is wrong, a page has changed, or a fact is out of date, write to hello@formblends.com with the evaluation URL and the company page that shows the problem. Companies and readers are handled the same way: we re-read the page, change the score if the definition no longer fits, and log the change with the date. We do not remove evaluations on request. We do not answer questions about individual medical situations; a licensed prescriber does that.

What this site is not

It is not medical advice, not legal advice, and not a recommendation of any program, including FormBlends. A high total means a company told you enough to check. Read the medical disclaimer before relying on anything here, and check the things that matter to you on the primary sources every evaluation links.

Sources (3)

  1. FormBlends Accessed September 4, 2026.
  2. FTC: Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 CFR Part 255 Accessed September 4, 2026.
  3. FTC: Trade Regulation Rule on the Use of Consumer Reviews and Testimonials, 16 CFR Part 465 Accessed September 4, 2026.